These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 14561005)

  • 21. Advanced breast cancer: a phase II trial with gemcitabine.
    Carmichael J; Possinger K; Phillip P; Beykirch M; Kerr H; Walling J; Harris AL
    J Clin Oncol; 1995 Nov; 13(11):2731-6. PubMed ID: 7595731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Veno-occlusive disease of the liver induced by gemcitabine.
    Dobbie M; Hofer S; Oberholzer M; Herrmann R
    Ann Oncol; 1998 Jun; 9(6):681. PubMed ID: 9681086
    [No Abstract]   [Full Text] [Related]  

  • 23. [Role of gemcitabine in treatment of metastatic breast cancer].
    Latipova DKh; Semiglazova TIu; Filatova LV; Gershanovich ML
    Vopr Onkol; 2011; 57(2):139-46. PubMed ID: 21809657
    [No Abstract]   [Full Text] [Related]  

  • 24. Gemcitabine pulmonary toxicity in ovarian cancer.
    Ko E; Lee S; Goodman A
    Oncologist; 2008 Jul; 13(7):807-11. PubMed ID: 18614588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic intraarterial chemotherapy with gemcitabine in patients with unresectable cholangiocarcinomas and liver metastases of pancreatic cancer: a clinical study on maximum tolerable dose and treatment efficacy.
    Vogl TJ; Schwarz W; Eichler K; Hochmuth K; Hammerstingl R; Jacob U; Scheller A; Zangos S; Heller M
    J Cancer Res Clin Oncol; 2006 Nov; 132(11):745-55. PubMed ID: 16858591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of gemcitabine in patients with advanced hepatocellular carcinoma.
    Yang TS; Lin YC; Chen JS; Wang HM; Wang CH
    Cancer; 2000 Aug; 89(4):750-6. PubMed ID: 10951336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemolytic-uremic syndrome caused by gemcitabine.
    Nackaerts K; Daenen M; Vansteenkiste J; Vandevelde A; Van Bleyenbergh P; Demedts M
    Ann Oncol; 1998 Dec; 9(12):1355. PubMed ID: 9932169
    [No Abstract]   [Full Text] [Related]  

  • 28. Gemcitabine: vascular toxicity and prothrombotic potential.
    Dasanu CA
    Expert Opin Drug Saf; 2008 Nov; 7(6):703-16. PubMed ID: 18983217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transarterial chemoembolisation (TACE) with gemcitabine: phase II study in patients with liver metastases of breast cancer.
    Eichler K; Jakobi S; Gruber-Rouh T; Hammerstingl R; Vogl TJ; Zangos S
    Eur J Radiol; 2013 Dec; 82(12):e816-22. PubMed ID: 24055389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of pancreatic cancer with local recurrence and liver metastases eight years after surgery].
    Taniguchi H; Mizuma M; Motoi F; Abe T; Okada R; Kawaguchi K; Karasawa H; Masuda K; Yabuuchi S; Fukase K; Sakata N; Okada T; Nakagawa K; Hayashi H; Morikawa T; Yoshida H; Naito T; Katayose Y; Egawa S; Unno M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2193-5. PubMed ID: 25731467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II trial of gemcitabine as prolonged infusion in metastatic breast cancer.
    Schmid P; Akrivakis K; Flath B; Grosse Y; Sezer O; Mergenthaler HG; Possinger K
    Anticancer Drugs; 1999 Aug; 10(7):625-31. PubMed ID: 10507311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of advanced pancreatic cancer showing remarkable response to gemcitabine treatment].
    Masaki T; Ohkawa S; Hirokawa S; Miyakawa K; Tamai S; Tarao K
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1333-6. PubMed ID: 14518416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Severe interstitial pneumonitis related to Gemcitabine].
    Sabria-Trias J; Bonnaud F; Sioniac M
    Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gemcitabine in advanced breast cancer.
    Possinger K
    Anticancer Drugs; 1995 Dec; 6 Suppl 6():55-9. PubMed ID: 8718426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Icotinib plus gemcitabine for metastatic pancreatic cancer: a case report.
    Zhao J; Shen H; Hu HG; Huang JJ
    World J Gastroenterol; 2015 Mar; 21(11):3441-6. PubMed ID: 25805958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma.
    Kuku I; Kaya E; Sevinc A; Aydogdu I
    J Eur Acad Dermatol Venereol; 2002 May; 16(3):271-2. PubMed ID: 12195570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer.
    Hoang T; Kim K; Jaslowski A; Koch P; Beatty P; McGovern J; Quisumbing M; Shapiro G; Witte R; Schiller JH
    Lung Cancer; 2003 Oct; 42(1):97-102. PubMed ID: 14512193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fatal liver failure associated with gemcitabine hydrochloride therapy].
    Matsuda M; Watanabe G; Mine S; Hashimoto M
    Gan To Kagaku Ryoho; 2008 Jan; 35(1):157-9. PubMed ID: 18195549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Favorable outcome of gemcitabine-induced respiratory distress syndrome.
    Girard T; Mouthon L; Boaziz C; Andre MH; Guillevin L
    Ann Med Interne (Paris); 2000 Jun; 151(4):306-8. PubMed ID: 10922960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [ASCO Annual Meeting 2004, New Orleans. Gemcitabine in metastatic breast carcinoma].
    Longo F; Mansueto G
    Tumori; 2004; 90(5):1-8. PubMed ID: 15656346
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.